On February 20, 2025, Robert Mcnamara, a Director at AVITA Medical Inc (RCEL), purchased 10,000 shares of the company, as reported in the SEC Filing. Following
We came across a bullish thesis on AVITA Medical, Inc. (RCEL) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc.
The mean of analysts' price targets for Avita Medical (RCEL) points to a 52.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Commercial Revenue: $18.4 million for Q4 2024, a 30% increase compared to Q4 2023.Full-Year Revenue: $64 million for 2024, a 29% increase from $49.8 million in
Feb 14, 2025 / 09:30PM GMTOperator Good day, and thank you for standing by. Welcome to the AVITA Medical fourth-quarter 2024 earnings conference call. (Operator
VALENCIA, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. ( RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transform
Financial writer upgrades RCEL stock to Buy due to growth potential, international expansion, and undervaluation post-guidance cut. Click here to read more.
We came across a bullish thesis on AVITA Medical, Inc. (NASDAQ:RCEL) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc.
Asian stock markets are trading mostly lower on Thursday, following the mixed cues from Wall Street overnight, amid uncertainty about the outlook for interest rates following mixed U.
Seattle-based biotechnology company Sana Biotechnology, Inc. (SANA) is up over 227 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Wednesday.
Shares of AVITA Medical, Inc RCEL fell sharply in t...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...